loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 209400 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 OMEPRAZOLE (1)

filter

01 DEXCEL (1)

filter

01 TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL (1)

filter

01 20MG (1)

filter

01 USA (1)

URL Supplier Web Content
TABLET, ORALLY DISINTE...
20MG
OMEPRAZOLE
USA
209400
2017-07-05
OTC
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 209400

Looking for CTD TGA MCC DOSSIER APPLICATION 209400 1

19

Dexcel Pharma, based in Israel, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is OMEPRAZOLE, with a corresponding application number 209400 and regulatory information .

proudly manufactured in the

approval since 2017-07-05

Dexcel Pharma's OMEPRAZOLE TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL, medication with 20MG of OMEPRAZOLE.

Post Enquiry
POST ENQUIRY